The dialyzers market has seen considerable growth due to a variety of factors.
• In recent years, the dialyzers market has experienced significant growth. Its value is expected to increase from $2.24 billion in 2024 to $2.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.4%.
The previously observed growth in this market is primarily due to factors such as an aging population, advancements in healthcare infrastructure, increased research and development, and a rise in the number of dialysis centers.
The dialyzers market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the dialyzers market is anticipated to witness robust growth, reaching a value of $3.12 billion in 2029, a compound annual growth rate (CAGR) of 7.3%.
The expected growth in this period is due to factors such as an increase in chronic kidney diseases, higher disposable income, increasing healthcare spending, and a growing demand for home dialysis treatments. Future trends in this forecast period include the utilization of wearable dialysis devices, the integration of artificial intelligence (AI), remote monitoring, the introduction of value-based care models, and the development of bioengineered dialyzers.
The dialyzer market is forecasted to expand due to the rising number of end-stage renal disease (ESRD) cases. ESRD, also known as end-stage renal failure (ESRF), is the final and irreversible phase of chronic kidney disease where the kidneys are no longer able to function independently. Dialyzers are vital in the dialysis process as they remove waste and excess fluid from the blood before reinfusing the cleansed blood back into the body of those suffering from ESRD. For example, as per the National Kidney Foundation in June 2024, a revolution from India is endeavoring to combat avoidable kidney disease and save lives, with nearly 35.5 million Americans diagnosed with chronic kidney disease by 2023. This constitutes 33% of adults, or more than one out of every three. It's also noteworthy that while Black/African American individuals represent 13% of the U.S. population, they account for 30% of all kidney failure cases. Kidney patients account for about a quarter of all Medicare expenses, which amount to a staggering $156.7 billion and is still rising. Hence, the growth in end-stage renal disease cases is fueling the demand in the dialyzer market.
The dialyzers market covered in this report is segmented –
1) By Type: High-Flux Dialyzers, Low-Flux Dialyzer
2) By Usage Type: Disposable, Reusable
3) By End-Uses: In-Centre Dialysis, Home Dialysis, Hospital Dialysis, Independent Dialysis, Peritoneal Dialysis, Home Hemodialysis
Subsegments:
1) By High-Flux Dialyzers: Polyethersulfone (PES) Dialyzers, Polysulfone (PS) Dialyzers, Polyacrylonitrile (PAN) Dialyzers
2) By Low-Flux Dialyzers: Cellulose Dialyzers, Cellulose Acetate Dialyzers, Synthetic Low-Flux Dialyzers
Major firms in the dialyzer market are prioritizing the creation of innovative products like hemocompatible dialyzers, to offer dependable service to patients. These specific dialyzers aim to limit the stimulation of the blood's clotting process and the inflammatory reaction, thereby decreasing the chances of problems occurring during dialysis, which may include blood clots, hemorrhaging, and infections. For example, Fresenius Medical Care AG & Co. KGaA, a dialyzer manufacturer based in Germany, in February 2024 introduced the 5008X Hemodialysis System. The 5008X Haemodialysis System along with its partner FX CorAL dialyser attest to the company's international innovation leadership in medical device and membrane engineering technologies. The 5008X Haemodialysis System blends cutting-edge device engineering and membrane technologies to facilitate high-volume hemodiafiltration.
Major companies operating in the dialyzers market include:
• Medtronic PLC
• Asahi Kasei Medical Co Ltd.
• Toray Medical Co Ltd.
• Baxter International Inc.
• B. Braun Melsungen AG
• Terumo Corporation
• Nipro Corporation
• Nikkiso Co Ltd.
• Weigao group
• Fresenius Medical Care AG & Co KGaA
• Allmed Medical Products Co Ltd.
• NxStage Medical Inc.
• Jiangxi Sanxin Medical Technology Co Ltd.
• Rockwell Medical Inc.
• Xenios AG.
• Kawasumi Laboratories Incorporated.
• Dialife SA
• Anhui Jinye Industrial Co Ltd.
• Haidylena
• and Farmasol S.A
North America was the largest region in the dialyzers market in 2024. The regions covered in the dialyzers market market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.